dactinomycin has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Hao, L; Huang, S; Wei, W; Wu, Z | 1 |
| Erkan, M; Friess, H; Kleeff, J; Pan, Z; Streit, S | 1 |
2 other study(ies) available for dactinomycin and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glycolysis; HEK293 Cells; Humans; Kaplan-Meier Estimate; Male; Mice, Nude; Pancreatic Neoplasms; Protein Binding; RNA Interference; RNA-Binding Proteins; RNA, Messenger; RNAi Therapeutics; Xenograft Model Antitumor Assays | 2019 |
Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Membrane Glycoproteins; Neoplasm Staging; Nucleic Acid Synthesis Inhibitors; Pancreatic Neoplasms; Prognosis; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection | 2009 |